Skip to ContentSkip to Navigation
Practical matters How to find us dr. G. (Gert) Luurtsema

Research interests

The research of Gert Luurtsema, associate professor at the UMCG, is focused on a broad range of topics, ranging from tracer development to validation of clinical imaging applications. With support of NWO-STW funding, he has accomplished a research line on imaging of the blood-brain barrier (BBB) integrity in relation to brain disorders and drug delivery. Besides this, he is supervising > 7 PhD students, 5 master students and 3 postdocs. Currently, he is (co-)author of more than 100 peer-reviewed scientific articles in high ranking journals and scientific textbooks. He was guest editor of the journals Current Pharmaceutical Design and Contrast Media & Molecular Imaging. 

Publications

A proof-of-concept study on the use of a fluorescein-based 18F-tracer for pretargeted PET

Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [ 18 F]MC225 and PET

Methods and equipment for quality control of radiopharmaceuticals

[18F]MC225 PET for the dose-response assessment of tariquidar inhibition of blood-brain barrier P-glycoprotein function in vivo

A new approach to produce [F-18]MC225 via one-step synthesis, a PET radiotracer for measuring P-gp function

Basic aspects of good manufacturing practice for PET-rediopharmaceuticals

Corrigendum: Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of F-18-Labeled PSMA-Tracers for Prostate Cancer Imaging (vol 26, pg 10871, 2020)

Cross-coupling of [11C]methyllithium for 11C-labelled PET tracer synthesis

EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality

Evaluation of P-glycoprotein function at the blood-brain barrier using [F-18]MC225-PET

Read more

Press/media

Diagnosi di malattie cerebrali oggi se ne parla a Triggiano

Diagnose van prostaatkanker bij Treant op topniveau